论文部分内容阅读
目的观察急性ST段抬高型心肌梗死(STEMI)患者行急诊经皮冠状动脉介入术(PCI)与同期行溶栓治疗的疗效。方法选择潍坊市人民医院急诊内科2013年7月~2014年10月首诊的STEMI患者120例,发病时间均在12h以内,其中行急诊PCI治疗80例,与同期溶栓治疗STEMI 40例进行疗效对比,比较两组患者的一般临床特点、血运重建率、心血管不良事件发生率、再灌注治疗后30d及90d的左室射血分数(LVEF)、住院病死率等。结果两组患者的一般临床特点无明显差异,急诊直接PCI组的血运重建率、心血管不良事件发生率、LVEF、住院病死率等均明显优于溶栓治疗组。结论对于STEMI患者在治疗条件允许的前提下应首选急诊PCI,急诊PCI治疗STEMI的总体效果及预后都明显优于溶栓治疗组。
Objective To observe the effect of emergent percutaneous coronary intervention (PCI) and concurrent thrombolysis in patients with acute ST-segment elevation myocardial infarction (STEMI). Methods We selected 120 patients with STEMI who were diagnosed first in our hospital from July 2013 to October 2014 in Weifang People’s Hospital. The onset time was within 12 hours. Among them, 80 cases were treated with emergency PCI and 40 cases were treated with STEMI in the same period The clinical features, revascularization rate, incidence of cardiovascular adverse events, left ventricular ejection fraction (LVEF) 30d and 90d after reperfusion therapy and hospital mortality were compared between the two groups. Results There was no significant difference in the general clinical features between the two groups. The rate of revascularization, incidence of adverse cardiovascular events, LVEF and in-hospital mortality were significantly higher in the direct PCI group than in the thrombolytic group. Conclusion STEMI patients should be the first choice of emergency PCI under the condition of treatment, and the overall effect and prognosis of STEMI in emergency PCI are better than thrombolytic therapy group.